Excessive glutamate receptor 1 immunoreactivity in adult down syndrome brains

Pediatric Neurology

Volumn 15, Issue 3, 1996, Pages 203-206

  Arai, Yasuhiro ^a   Mizuguchi, Masashi ^a   Takashima, Sachio ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTE; BRAIN CORTEX; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; NEWBORN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; SENILE PLAQUE;

ADOLESCENT; ADULT; BRAIN CHEMISTRY; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; DEMENTIA; DOWN SYNDROME; HUMANS; INFANT; INFANT, NEWBORN; NEURONS; RECEPTORS, GLUTAMATE;

EID: 0030273428     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(96)00167-1     Document Type: Article

References (15)

1. 2+ in mammalian neurons. Trends Pharmacol Sci 1990;11:254-60.
2. [2] Monaghan DT, Olverman HJ, Nguyen L, Watkins JC, Cotman CW. Two classes of N-methyl-D-asparate recognition sites: Differential distribution and differential regulation by glycine. Proc Natl Acad Sci USA 1988;85:9836-40.
3. [3] Mayer ML, Westbrook GL. The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 1987;28: 197-276.
4. [4] Petralia RS, Wenthold RJ. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J Comp Neurol 1992;318:329-54.
5. [5] Takashima S, Becker LE, Armstrong D, Chan F. Abnormal neuronal development in the visual cortex of the human fetus and infant with Downs syndrome. A quantitative and qualitative Golgi study. Brain Res 1981;225:1-21.
6. [6] Takashima S, Becker LE. Developmental changes of glial fibrillary acidic protein in cerebral white matter. Arch Neurol 1983;40: 14-8.
7. [7] Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloid. Lab Invest 1987;57:230-6.
8. [8] Fonnum F. Glutamate: A neurotransmitter in mammalian brain. J Neurochem 1984;42:1-11.
9. [9] Sandoval ME, Cotman CW. Evaluation of glutamate as a neurotransmitter of cerebellar parallel fibers. Neuroscience 1978;3:199-206.
10. [10] Drejer J, Benveniste H, Diemer NH, Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem 1985;45:145-51.
11. [11] Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-34.
12. [12] Takashima S, Kuruta H, Mito T, Nishizawa M, Kunishita T, Tabira T. Developmental and aging changes in the expression patterns of beta-amyloid in the brains of normal and Down syndrome case. Brain Dev 1990;12:102-5.
13. [13] Lee KR, Wurtman RJ, Cox AJ, Nitsch RM. Amyloid precursor protein processing is stimulated by metabolic glutamate receptors. Proc Nad Acad Sci USA 1995;92:8083-7.
14. [14] Hollmann M, Hartley M, Heinemann S. Calcium permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 1991;252:851-3.
15. [15] McNamara JO, Eubanks JH, McPherson JD, Wasmuth JJ, Evans GA, Heinemann SF. Chromosomal localization of human glutamate receptor genes. J Neurosci 1992;12:2555-62.